Arne Scheu

Arne Scheu

Company: Valink Therapeutics

Job title: Chief Executive Officer

Seminars:

Spotlighting Synergy: Embracing a Holistic & High-Throughput Approach to Revolutionise the Development of Fragment-Based Novel Conjugate Drugs 9:30 am

Explore the paradigm shift towards a holistic approach to conjugate design, where equal emphasis is placed on optimizing each component – from payload to linker to targeting binders – to maximize therapeutic efficacy and minimize off-target effects Delve into the innovative methodologies enabling rapid iteration and high-throughput screening of conjugates, allowing for the creation of…Read more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.